Detalles de la búsqueda
1.
Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy.
Ann Surg Oncol
; 31(6): 3872-3879, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353798
2.
Prognostic impact of histological discordance between transurethral resection and radical cystectomy.
BJU Int
; 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38344879
3.
Treatment patterns and prognosis in patients with Bacillus Calmette-Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis.
World J Urol
; 42(1): 185, 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512511
4.
The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin therapy.
Jpn J Clin Oncol
; 54(2): 192-200, 2024 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37974430
5.
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Int J Urol
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722221
6.
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohort.
Int J Urol
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424729
7.
Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi-institutional study.
Int J Urol
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822533
8.
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapy.
Int J Urol
; 31(5): 526-533, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240169
9.
Comparison of therapeutic features and oncologic outcome in patients with pN1 prostate cancer among robot-assisted, laparoscopic, or open radical prostatectomy.
Int J Clin Oncol
; 28(2): 306-313, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527579
10.
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysis.
Int J Urol
; 30(3): 299-307, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448522
11.
Radiotherapy plus androgen deprivation therapy for prostate-specific antigen persistence in lymph node-positive prostate cancer.
Cancer Sci
; 113(7): 2386-2396, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485635
12.
Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Jpn J Clin Oncol
; 52(12): 1430-1435, 2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36093731
13.
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
Int J Clin Oncol
; 27(5): 958-968, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35142962
14.
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomy.
Int J Urol
; 29(3): 242-249, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902876
15.
Clinical practice pattern in patients with advanced urothelial cancer who had progressed on pembrolizumab in the pre-enfortumab vedotin era.
Int J Urol
; 29(7): 647-655, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304776
16.
Real-world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette-Guérin failure in non-muscle-invasive bladder cancer.
Int J Urol
; 29(10): 1195-1203, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858755
17.
Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.
Int J Clin Oncol
; 26(11): 2104-2112, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34313904
18.
Perioperative therapies for urological cancers.
Jpn J Clin Oncol
; 50(4): 357-367, 2020 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32115649
19.
Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
Jpn J Clin Oncol
; 50(12): 1464-1469, 2020 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32699909
20.
The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.
BMC Urol
; 20(1): 110, 2020 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32711491